leucovorin calcium - Profile
✉ Email this page to a colleague
What are the generic drug sources for leucovorin calcium and what is the scope of patent protection?
Leucovorin calcium
is the generic ingredient in four branded drugs marketed by Hospira, Abic, Abraxis Pharm, Elkins Sinn, Gland, Hainan Poly, Hikma, Meitheal, Pharmachemie, Pharmachemie Usa, Teva Parenteral, Teva Pharms Usa, Am Regent, Fresenius Kabi Usa, Mylan Labs Ltd, Sagent Pharms, Sagent Pharms Inc, Glaxosmithkline, Ingenus Pharms Llc, Avyxa Holdings, Ani Pharms, Barr, Epic Pharma Llc, Leading, Par Pharm, and Xanodyne Pharm, and is included in fifty-five NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.Summary for leucovorin calcium
| US Patents: | 1 |
| Tradenames: | 4 |
| Applicants: | 26 |
| NDAs: | 55 |
US Patents and Regulatory Information for leucovorin calcium
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospira | LEUCOVORIN CALCIUM | leucovorin calcium | FOR SOLUTION;ORAL | 008107-003 | Jan 30, 1987 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Abic | LEUCOVORIN CALCIUM | leucovorin calcium | INJECTABLE;INJECTION | 089353-001 | Jun 1, 1988 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Abraxis Pharm | LEUCOVORIN CALCIUM | leucovorin calcium | INJECTABLE;INJECTION | 088939-001 | Dec 1, 1986 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Elkins Sinn | LEUCOVORIN CALCIUM | leucovorin calcium | INJECTABLE;INJECTION | 070480-001 | Jan 2, 1987 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
